{"name":"Ottimo Pharma Limited","slug":"ottimo-pharma-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxNVEpHVlVraTY2R0hkRWZpMW5kb3V3UnUtY2FiUkU0VVNEb3FtcTB0anc0TnJhQWplR3cxOHhXeHVHMGhTMTdjeGtrVkRQM0owMktsdWtFUXJJTFl4M2J2d2Z2Tks5SjljMEp2bkd6NFEzbEtxRTc2SXd2RGNRcGxOT3hza29LTHZNY05KWGtKeFBIZ1dZNlM3NGlNYnpDLThYeGNMOFVzS2E4eWg0bnB1OTVnaHR2THZKaTZ0LXV3TGJWUlc4WTBqRGhjMngxU2JKTnh3TFhSNHh0bm1HYjJuVmJnbzVTSjNCUnBkcnJTbHIzeWw4TmhlRl83cXVocEdNcFRxYVI0aDhDelhITFR1WFJVakRTNmNLak9xTk05NVpnSmVhdUhyWnJCcktaV25hQTBKR1owVS0yMnA1UjRrVDhhc0pOdDU3Z21uenBlREx4TjdLcUE?oc=5","date":"2026-01-07","type":"regulatory","source":"GlobeNewswire","summary":"Ottimo Pharma Announces FDA Clearance of Investigational New Drug (IND) Application for OTP-01, a First-in-Class, Dual-Paratopic, Single-Agent, Anti-PD-1/VEGFR2 Antibody - GlobeNewswire","headline":"Ottimo Pharma Announces FDA Clearance of Investigational New Drug (IND) Application for OTP-01, a First-in-Class, Dual-P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPWENpWEZfN1FKNS04QTlJaWltaVp0dlpkcmM2TXhNMnFkcG9pTmE1WG9BMXVvUm92MmVpZmJyWk56Zk53M0dsLWxaS1VsOTRvLU5ka2taYU1CeGRnLWI1RGlIWEtVNXdfWkl3Mi1mWGNWOHAxRGtJem5JMlVSTHpwNy14QmVxdzBnbkRiZXQxUkpsRVZaQmRDSVRWSW5HVVlOeHNlUnZCekJRZw?oc=5","date":"2025-08-27","type":"deal","source":"Contract Pharma","summary":"Asimov, Ottimo Pharma Enter Cell Line Development Partnership - Contract Pharma","headline":"Asimov, Ottimo Pharma Enter Cell Line Development Partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxORnk5ZFd4djhYNWlSUnVwTmZacnBURWE1aEpwMDhfaWdPRmZiZEtoWXlLTGFpVGpOMVQ3b1lYMHlGN090OTdzMktFc2RleXVwLXJiM2lIS0RYellBbEl6V0FLeEVuS3Q4UHQ2T3lJNHBEcHZ1czZoM2lzcUVpOEN4MjBBV18tcExwblFWUkQzTE12NTZuZHBCS1ZRU0pBbEpZMF9FLXdQNEtWd0hYdGpTbHEwWndXWEUzWTFZVHpmN0xMVE96TXNxOUktUWxoa3U5LWlLakpna3o5MFQ3U0RYWVpKUGY1LWNYREZv?oc=5","date":"2025-06-19","type":"pipeline","source":"Korea JoongAng Daily","summary":"Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate - Korea JoongAng Daily","headline":"Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPUnlTQjNfb2RuQ0ljR3ppTkZ3QzdpZDFpUEEzSVJHMWswT3hIWVJUbzFfcVk1MkE5Z0N2SFNjRi1CdDdZWENmS3lYc1ZPS1QxaklubGg4Zlo5VzBYTmJBdG9BM3V5bjYyRG5CV0h2TDI3bFBGTUl5UUJrb2Q0ckhtRW1JSUdMeTd1clZ0OE1YZzVfWk5SdGNiUDJrUWtsdzNYU1JTU2pCaU1ReHozdFZJdlBR?oc=5","date":"2025-06-19","type":"pipeline","source":"Contract Pharma","summary":"LOTTE Biologics, Ottimo Pharma Sign Antibody Manufacturing Contract - Contract Pharma","headline":"LOTTE Biologics, Ottimo Pharma Sign Antibody Manufacturing Contract","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPUHVSMjNJSFhpeFhqMVJwZDRvM180Mkk5RV9lYVdlcWctMjlyblM4Umd3UExSUERwWmUzSlU3ZnNYWF8xYlFaUFVwTENQc01zdnZzN1c5V2pqR1N1UWhuVHB6SXlSelJDTWRIS0NJZWJ5YkxUWkZ5VnZIVWdFWHpvRkszd0c2ZzFsbVBaejlvMTFPdHZPUjN5eVN3eXdvSXBGeVBnQXBzZFhKdW0tMmdkVVlncjFOVGdmR0ZGNmJkUGtyYmY1S1pOUFQ3R3R2cWM?oc=5","date":"2025-04-11","type":"pipeline","source":"BioSpace","summary":"Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors - BioSpace","headline":"Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxON2l3c2FRSmVjUUlKMFp1eFRyS1Y2TF9WX19mM3RZTW1NTEVHck03NzMzZ3VfWXdtZURqeHFEei1BQnZMRFgtM3gxSVRsbFFNOGd6eVpkQ18xY1FsUWN5bUVpWDhFSTFpdy1qUXVIbENxMXoxUzAybWF5VnV0N09rX2NYV3V4Z0QzQ2pkUFVNY1ZjZG5mUmRCaE9IbWQ0N1FGb0t1V0xtaw?oc=5","date":"2024-12-19","type":"pipeline","source":"BioPharma Dive","summary":"Ottimo raises $140M to compete in chase for new type of cancer drug - BioPharma Dive","headline":"Ottimo raises $140M to compete in chase for new type of cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9BajQtV3RKWV9KNHB1OURPWDdkV01LRi11Qi1YRWU2bUFuVW15RFo4c2x3VGFfU3J4cDdKYmVIS2w5YTlwLVRQaE9WbkRYY1JOa3BDR2ZQSGd4WXFFUWZ4NTZJN3ZGSmdtTXpUODVtMVdiQ24tWWxhbEdxSEJmZw?oc=5","date":"2024-12-19","type":"pipeline","source":"pharmaphorum","summary":"Ottimo raises $140m for its PD-1/VEGF cancer drug - pharmaphorum","headline":"Ottimo raises $140m for its PD-1/VEGF cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE9rbEMtbmpkV0g5UmJObExrRTdyTmV2czB0MEQ1WlR3a0lNQy15WVBEUEdPMF9mT3IwR0xNa3J1eEI3UExRQ2lCN1BxbUVYYVNXZ0wzWHhMeTRGdkk?oc=5","date":"2024-10-30","type":"pipeline","source":"Oncodaily","summary":"The Launch of Ottimo Pharma - Oncodaily","headline":"The Launch of Ottimo Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQUzJzQ0FkUVFzRWlRcmV5SDRlT1IxT3dnMFNqbE1hRWJjUHJnaE9zd1ljS0Fia2FwNU5ORHctcXVNalRmSTRReWl2SUtUVGMxNmxZdE5OTXZOUlNhRXdXRURVNmxiZExJLXZ1UTJidFFzbFRpREktbnpvbWxld29wYXFOZngwUkdueC00bGdxcHVEcnBWaTdDSUVBdktBYmtSX2RTcW1nYlJUcTEyb3JpTg?oc=5","date":"2024-10-28","type":"pipeline","source":"BioWorld News","summary":"Ottimo Pharma emerges from stealth with focus on solid tumor therapies - BioWorld News","headline":"Ottimo Pharma emerges from stealth with focus on solid tumor therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQTUxqWlpBc2xCcjBWSkJDRHNsZ1V5WkJwbHUzNlJ5U2VyWGZOXy1nY2pjblFnUGhuSW0zdmE4TFEzeGluV25pTC1uNUhYN1VlT2Z1bVRnNWEweTM0ZG9ncldmOUd3dnVnaHFnZm5JOUthd1Q5MC16N2M2MjlFQU8tU2wtN3B1Sm1fTk9vVXgxT2JFaE1QT2V2empXeThvYm1HazlkNW1XRGZac2w0VkE?oc=5","date":"2024-10-28","type":"pipeline","source":"Bloomberg.com","summary":"Seagen’s Ex-CEO Starts Company to Develop Drug Tackling Wide Range of Cancers - Bloomberg.com","headline":"Seagen’s Ex-CEO Starts Company to Develop Drug Tackling Wide Range of Cancers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}